News 2024 News MENU 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 All Topics Press Release IR Dec. 9, 2024 Topics One of the largest biodiesel fuel production plants in Japan uses Polyplastics-Evonik's "PURAMEM®" membrane and has started commercial operation Dec. 6, 2024 Topics 3D printing structure using Daicel's cellulose acetate resin "CAFBLO" recognized by Guinness World Records as the Largest 3D-Printed biodegradable building (monolithic). ～ “Foresting Architecture” at the Expo 2025 Osaka-Kansai Expo site ～ Dec. 3, 2024 Topics Notice Concerning the Status of acquisition of Treasury Stocks [PDF:31.3 KB] Nov. 29, 2024 Topics Polyplastics POM plant starts operations in China November 29, 2024 Nov. 12, 2024 Topics Notice Concerning Result of Acquisition of Treasury Stock through Own Shares Through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3) [PDF:62.0 KB] Nov. 11, 2024 Topics Notice Concerning the Acquisition of Treasury Stock through the Tokyo Stock Exchange Trading NeTwork System-3 [PDF:62.8 KB] Nov. 7, 2024 IR 1st Half of Fiscal Year ending March 2025 Consolidated Financial Results [PDF:1.7 MB] Nov. 7, 2024 IR Consolidated Financial Results for the Six Months Ended September 30, 2024 [PDF:264.9 KB] Nov. 7, 2024 IR Notice Regarding Revision to Consolidated Financial Forecast [PDF:66.8 KB] Nov. 7, 2024 IR Notice Regarding Retained Earnings Dividend (Interim Dividend) and Revision of Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2025 (dividend increase) [PDF:117.2 KB] Nov. 7, 2024 IR Notice Concerning the Decision of the Acquisition of Treasury Stock [PDF:105.5 KB] Oct. 31, 2024 Topics Notice of Publication of English Version of Daicel Report 2024 Aug. 26, 2024 Topics Notice Regarding Completion of payment for Disposal of Treasury Stock as Restricted Stock Incentive for Daicel Employee Shareholding Associations and Partial Forfeiture [PDF:106.9 KB] Aug. 2, 2024 IR 1st Quarter Consolidated Financial Results for the Year Ending March 31, 2025 [PDF:148.0 KB] Aug. 2, 2024 IR 1st Quarter(Apr. to Jun.) of Fiscal Year ending March 2025 Consolidated Financial Results [PDF:1.3 MB] Aug. 2, 2024 IR Notice Regarding Completion of Disposal of Treasury Stock as Restricted Stock Compensation Plan [PDF:83.8 KB] Jul. 4, 2024 Topics Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation [PDF:125.2 KB] Jul. 4, 2024 Topics Notice Regarding Disposal of Treasury Stock as Restricted Stock Incentive for Daicel Employee Shareholding Association [PDF:172.4 KB] Jun. 25, 2024 Topics Notice of Results of Exercise of Voting Rights at the 158th Annual General Meeting of Shareholders [PDF:155.3 KB] Jun. 18, 2024 Topics Ransomware at Group Company in France May 24, 2024 IR NOTICE OF THE 158TH ANNUAL GENERAL MEETING OF SHAREHOLDERS [PDF:762.2 KB] May 15, 2024 Press Release Daicel Medical Ltd. Obtains a Second-class marketing license for medical devices. May 9, 2024 IR Consolidated Financial Results for the Year Ended March 31, 2024 [PDF:209.2 KB] May 9, 2024 IR Fiscal Year ended March 2024 Consolidated Financial Results [PDF:2.2 MB] May 9, 2024 IR Notice Concerning Change in Shareholder Return Policy (DOE index introduction) [PDF:59.1 KB] May 9, 2024 IR Notice Concerning Cancellation of Treasury Shares [PDF:44.2 KB] May 9, 2024 IR Notice Regarding Revision of Restricted Stock Compensation Plan [PDF:60.5 KB] Apr. 15, 2024 Press Release Lecture by Prof. Satoshi Uchida, Tokyo Medical and Dental University at the World Vaccine Congress 2024, USA Research on mRNA vaccines using DAICEL's "Actranza® lab." Apr. 10, 2024 Press Release DAICEL and ITRI Sign Partnership Agreement to Support Startups Mar. 28, 2024 Topics <ALERT> Please be aware of suspicious emails and documents attempting to deceive recipients by impersonating Daicel executives/employees [PDF:108.6 KB] Mar. 26, 2024 IR Notice Concerning the Status and Completion of Acquisition of Treasury Stocks [PDF:60.6 KB] Mar. 19, 2024 Topics Notification of Establishment of Joint Venture by Daicel Corporation and Inabata & Co., Ltd. Mar. 4, 2024 IR Notice Concerning the Status of acquisition of Treasury Stocks [PDF:59.5 KB] Feb. 26, 2024 IR Notice Concerning Change in Major Shareholders [PDF:66.5 KB] Feb. 19, 2024 Press Release Transfer of Daicel Pyrotechnics LTD. to Sightron Japan Inc. Feb. 6, 2024 IR 3rd Quarter Consolidated Financial Results for the Year Ending March 31, 2024 [PDF:134.1 KB] Feb. 6, 2024 IR 3rd Quarter of Fiscal Year ending March 2024 Consolidated Financial Results [PDF:865.9 KB] Feb. 2, 2024 IR Notice Concerning the Status of acquisition of Treasury Stocks [PDF:59.2 KB] Jan. 5, 2024 IR Notice Concerning the Status of acquisition of Treasury Stocks [PDF:58.8 KB]
Dec. 9, 2024 Topics One of the largest biodiesel fuel production plants in Japan uses Polyplastics-Evonik's "PURAMEM®" membrane and has started commercial operation
Dec. 6, 2024 Topics 3D printing structure using Daicel's cellulose acetate resin "CAFBLO" recognized by Guinness World Records as the Largest 3D-Printed biodegradable building (monolithic). ～ “Foresting Architecture” at the Expo 2025 Osaka-Kansai Expo site ～
Nov. 12, 2024 Topics Notice Concerning Result of Acquisition of Treasury Stock through Own Shares Through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3) [PDF:62.0 KB]
Nov. 11, 2024 Topics Notice Concerning the Acquisition of Treasury Stock through the Tokyo Stock Exchange Trading NeTwork System-3 [PDF:62.8 KB]
Nov. 7, 2024 IR 1st Half of Fiscal Year ending March 2025 Consolidated Financial Results [PDF:1.7 MB]
Nov. 7, 2024 IR Consolidated Financial Results for the Six Months Ended September 30, 2024 [PDF:264.9 KB]
Nov. 7, 2024 IR Notice Regarding Retained Earnings Dividend (Interim Dividend) and Revision of Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2025 (dividend increase) [PDF:117.2 KB]
Aug. 26, 2024 Topics Notice Regarding Completion of payment for Disposal of Treasury Stock as Restricted Stock Incentive for Daicel Employee Shareholding Associations and Partial Forfeiture [PDF:106.9 KB]
Aug. 2, 2024 IR 1st Quarter Consolidated Financial Results for the Year Ending March 31, 2025 [PDF:148.0 KB]
Aug. 2, 2024 IR 1st Quarter(Apr. to Jun.) of Fiscal Year ending March 2025 Consolidated Financial Results [PDF:1.3 MB]
Aug. 2, 2024 IR Notice Regarding Completion of Disposal of Treasury Stock as Restricted Stock Compensation Plan [PDF:83.8 KB]
Jul. 4, 2024 Topics Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation [PDF:125.2 KB]
Jul. 4, 2024 Topics Notice Regarding Disposal of Treasury Stock as Restricted Stock Incentive for Daicel Employee Shareholding Association [PDF:172.4 KB]
Jun. 25, 2024 Topics Notice of Results of Exercise of Voting Rights at the 158th Annual General Meeting of Shareholders [PDF:155.3 KB]
May 15, 2024 Press Release Daicel Medical Ltd. Obtains a Second-class marketing license for medical devices.
May 9, 2024 IR Notice Concerning Change in Shareholder Return Policy (DOE index introduction) [PDF:59.1 KB]
Apr. 15, 2024 Press Release Lecture by Prof. Satoshi Uchida, Tokyo Medical and Dental University at the World Vaccine Congress 2024, USA Research on mRNA vaccines using DAICEL's "Actranza® lab."
Mar. 28, 2024 Topics <ALERT> Please be aware of suspicious emails and documents attempting to deceive recipients by impersonating Daicel executives/employees [PDF:108.6 KB]
Mar. 26, 2024 IR Notice Concerning the Status and Completion of Acquisition of Treasury Stocks [PDF:60.6 KB]
Mar. 19, 2024 Topics Notification of Establishment of Joint Venture by Daicel Corporation and Inabata & Co., Ltd.
Feb. 6, 2024 IR 3rd Quarter Consolidated Financial Results for the Year Ending March 31, 2024 [PDF:134.1 KB]
Feb. 6, 2024 IR 3rd Quarter of Fiscal Year ending March 2024 Consolidated Financial Results [PDF:865.9 KB]
